{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T13:46:35Z","timestamp":1784123195063,"version":"3.55.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100007899","name":"University of Arizona","doi-asserted-by":"publisher","award":["119187"],"award-info":[{"award-number":["119187"]}],"id":[{"id":"10.13039\/100007899","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["T32 GM008804"],"award-info":[{"award-number":["T32 GM008804"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.antiviral.2018.03.002","type":"journal-article","created":{"date-parts":[[2018,3,5]],"date-time":"2018-03-05T23:04:34Z","timestamp":1520291074000},"page":"10-22","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Profiling the in vitro drug-resistance mechanism of influenza A viruses towards the AM2-S31N proton channel blockers"],"prefix":"10.1016","volume":"153","author":[{"given":"Rami","family":"Musharrafieh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunlong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2018.03.002_bib1","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1128\/AAC.49.2.556-559.2005","article-title":"Generation and characterization of recombinant influenza A (H1N1) viruses harboring amantadine resistance mutations","volume":"49","author":"Abed","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2018.03.002_bib2","doi-asserted-by":"crossref","first-page":"15075","DOI":"10.1073\/pnas.1007071107","article-title":"Structure and mechanism of proton transport through the transmembrane tetrameric M2 protein bundle of the influenza A virus","volume":"107","author":"Acharya","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2018.03.002_bib3","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.bbamem.2010.06.018","article-title":"Resistance characteristics of influenza to amino-adamantyls","volume":"1808","author":"Astrahan","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.antiviral.2018.03.002_bib4","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1021\/bi901799k","article-title":"Functional studies and modeling of pore-lining residue mutants of the influenza A virus M2 ion channel","volume":"49","author":"Balannik","year":"2010","journal-title":"Biochemistry"},{"key":"10.1016\/j.antiviral.2018.03.002_bib200","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0168-9525(00)88978-7","article-title":"Whole-mount immunohistochemistry on Xenopus embryos using far-red fluorescent dyes","volume":"11","author":"Beumer","year":"1995","journal-title":"Trends Genet."},{"key":"10.1016\/j.antiviral.2018.03.002_bib5","doi-asserted-by":"crossref","first-page":"3442","DOI":"10.1128\/AAC.01385-09","article-title":"In vitro system for modeling influenza A virus resistance under drug pressure","volume":"54","author":"Brown","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2018.03.002_bib6","doi-asserted-by":"crossref","first-page":"7356","DOI":"10.1021\/bi9008837","article-title":"Structure and function of the influenza A M2 proton channel","volume":"48","author":"Cady","year":"2009","journal-title":"Biochemistry"},{"key":"10.1016\/j.antiviral.2018.03.002_bib7","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1038\/nrd2175","article-title":"Antiviral agents active against influenza A viruses","volume":"5","author":"De Clercq","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.antiviral.2018.03.002_bib8","article-title":"Adamantane-resistant influenza A viruses in the world (1902\u20132013): frequency and distribution of M2 gene mutations","volume":"13","author":"Dong","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2018.03.002_bib9","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1021\/jm101334y","article-title":"Exploring the size limit of templates for inhibitors of the M2 ion channel of influenza A virus","volume":"54","author":"Duque","year":"2011","journal-title":"J. Med. Chem."},{"issue":"Suppl. 2","key":"10.1016\/j.antiviral.2018.03.002_bib10","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1186\/1471-2156-16-S2-S3","article-title":"Investigation of a recent rise of dual amantadine-resistance mutations in the influenza A M2 sequence","volume":"16","author":"Durrant","year":"2015","journal-title":"BMC Genet."},{"key":"10.1016\/j.antiviral.2018.03.002_bib11","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0042-6822(92)91187-Y","article-title":"Maturation of influenza A virus hemagglutinin-estimates of the pH encountered during transport and its regulation by the M2 protein","volume":"8","author":"Grambas","year":"1992","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2018.03.002_bib12","doi-asserted-by":"crossref","first-page":"4139","DOI":"10.1128\/JCM.43.8.4139-4146.2005","article-title":"Enhanced expression of an alpha2,6-linked sialic acid on MDCK cells improves isolation of human influenza viruses and evaluation of their sensitivity to a neuraminidase inhibitor","volume":"43","author":"Hatakeyama","year":"2005","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.antiviral.2018.03.002_bib13","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1002\/j.1460-2075.1985.tb04038.x","article-title":"The molecular basis of the specific anti-influenza action of amantadine","volume":"4","author":"Hay","year":"1985","journal-title":"EMBO J."},{"key":"10.1016\/j.antiviral.2018.03.002_bib14","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.bbamem.2010.09.014","article-title":"Conformational plasticity of the influenza A M2 transmembrane helix in lipid bilayers under varying pH, drug binding, and membrane thickness","volume":"1808","author":"Hu","year":"2011","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.antiviral.2018.03.002_bib15","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.antiviral.2017.01.006","article-title":"An M2-V27A channel blocker demonstrates potent in vitro and in vivo antiviral activities against amantadine-sensitive and -resistant influenza A viruses","volume":"140","author":"Hu","year":"2017","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2018.03.002_bib16","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.antiviral.2009.03.003","article-title":"Emergence and spread of oseltamivir-resistant A(H1N1) influenza viruses in Oceania, South East Asia and South Africa","volume":"83","author":"Hurt","year":"2009","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2018.03.002_bib17","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1056\/NEJMc1111078","article-title":"Community transmission of oseltamivir-resistant A(H1N1)pdm09 influenza","volume":"365","author":"Hurt","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2018.03.002_bib18","article-title":"Neuraminidase inhibitors for preventing and treating influenza in adults and children (Review)","volume":"4","author":"Jefferson","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.antiviral.2018.03.002_bib19","doi-asserted-by":"crossref","first-page":"4629","DOI":"10.1021\/jm500598u","article-title":"Aminoadamantanes with persistent in vitro efficacy against H1N1 (2009) influenza A","volume":"57","author":"Kolocouris","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2018.03.002_bib20","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1099\/vir.2008.007260-0","article-title":"High prevalence of amantadine resistance among circulating European porcine influenza A viruses","volume":"90","author":"Krumbholz","year":"2009","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2018.03.002_bib21","doi-asserted-by":"crossref","first-page":"10","DOI":"10.2807\/ese.16.05.19784-en","article-title":"Continued emergence and changing epidemiology of oseltamivir-resistant influenza A(H1N1)2009 virus, United Kingdom, winter 2010\/11","volume":"16","author":"Lackenby","year":"2011","journal-title":"Euro Surveill."},{"key":"10.1016\/j.antiviral.2018.03.002_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1001005","article-title":"Quasispecies theory and the behavior of RNA viruses","volume":"6","author":"Lauring","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2018.03.002_bib23","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1021\/acs.jmedchem.6b01852","article-title":"Expeditious lead optimization of isoxazole-containing influenza A virus M2-S31N inhibitors using the Suzuki\u2212Miyaura cross-coupling reaction","volume":"60","author":"Li","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2018.03.002_bib24","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1021\/acs.jmedchem.5b01910","article-title":"Discovery of highly potent inhibitors targeting the predominant drug-resistant S31N mutant of the influenza A virus M2 proton channel","volume":"59","author":"Li","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2018.03.002_bib25","doi-asserted-by":"crossref","first-page":"12283","DOI":"10.1073\/pnas.0905726106","article-title":"Identification of the functional core of the influenza A virus A\/M2 proton-selective ion channel","volume":"106","author":"Ma","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2018.03.002_bib26","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.bbamem.2017.10.026","article-title":"Functional studies reveal the similarities and differences between AM2 and BM2 proton channels from influenza viruses","volume":"1860","author":"Ma","year":"2018","journal-title":"BBA - Biomembr."},{"key":"10.1016\/j.antiviral.2018.03.002_bib27","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1124\/mol.116.105346","article-title":"Pharmacological characterizations of the spectrum of antiviral activity and genetic barrier of drug resistance of M2-S31N channel blockers","volume":"90","author":"Ma","year":"2016","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.antiviral.2018.03.002_bib28","series-title":"Textbook of Influenza","first-page":"20","article-title":"Influenza pandemics: history and lessons learned","author":"Monto","year":"2013"},{"key":"10.1016\/j.antiviral.2018.03.002_bib29","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1056\/NEJMra050740","article-title":"Neuraminidase inhibitors for influenza","volume":"353","author":"Moscona","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2018.03.002_bib30","doi-asserted-by":"crossref","first-page":"5000","DOI":"10.1073\/pnas.94.10.5000","article-title":"The active oligomeric state of the minimalistic influenza virus M2 ion channel is a tetramer","volume":"94","author":"Sakaguchi","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2018.03.002_bib31","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1086\/375799","article-title":"High frequency of resistant viruses harboring different mutations in amantadine-treated children with influenza","volume":"1","author":"Shiraishi","year":"2003","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2018.03.002_bib32","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/cid\/ciq012","article-title":"Estimating the burden of 2009 pandemic influenza A (H1N1) in the United States (April 2009\u2013April 2010)","volume":"52","author":"Shrestha","year":"2011","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2018.03.002_bib33","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.str.2008.04.011","article-title":"The interplay of functional tuning, drug resistance, and thermodynamic stability in the evolution of the M2 proton channel from the influenza A virus","volume":"16","author":"Stouffer","year":"2008","journal-title":"Structure"},{"key":"10.1016\/j.antiviral.2018.03.002_bib34","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s10156-003-0262-6","article-title":"Emergence of amantadine-resistant influenza A viruses: epidemiological study","volume":"9","author":"Suzuki","year":"2003","journal-title":"J. Infect. Chemother."},{"key":"10.1016\/j.antiviral.2018.03.002_bib35","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1128\/JVI.76.3.1391-1399.2002","article-title":"Influenza A virus M2 ion channel activity is essential for efficient replication in tissue culture","volume":"76","author":"Takeda","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.03.002_bib36","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/bip.22623","article-title":"Recent progress in designing inhibitors that target the drug-resistant M2 proton channels from the influenza A viruses","volume":"104","author":"Wang","year":"2015","journal-title":"Biopolymers"},{"key":"10.1016\/j.antiviral.2018.03.002_bib37","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1073\/pnas.1216526110","article-title":"Structure and inhibition of the drug-resistant S31N mutant of the M2 ion channel of influenza A virus","volume":"110","author":"Wang","year":"2013","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.antiviral.2018.03.002_bib38","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1021\/acs.jmedchem.7b01536","article-title":"In vitro pharmacokinetic optimizations of AM2-S31N channel blockers led to the discovery of slow-binding inhibitors with potent antiviral activity against drug-resistant influenza A viruses","volume":"61","author":"Wang","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2018.03.002_bib39","doi-asserted-by":"crossref","first-page":"17987","DOI":"10.1021\/ja508461m","article-title":"Flipping in the pore: discovery of dual inhibitors that bind in different orientations to the wild-type versus the amantadine-resistant S31N mutant of the influenza A virus M2 proton channel","volume":"136","author":"Wu","year":"2014","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.antiviral.2018.03.002_bib40","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1128\/JCM.01532-09","article-title":"Genetic makeup of amantadine-resistant and oseltamivir-resistant human influenza A\/H1N1 viruses","volume":"48","author":"Zaraket","year":"2010","journal-title":"J. Clin. Microbiol."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354218300652?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354218300652?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,15]],"date-time":"2022-08-15T04:28:20Z","timestamp":1660537700000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354218300652"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":41,"alternative-id":["S0166354218300652"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2018.03.002","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Profiling the in vitro drug-resistance mechanism of influenza A viruses towards the AM2-S31N proton channel blockers","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2018.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}